Eli Lilly EPS - Earnings per Share 2010-2025 | LLY

Eli Lilly earnings per share (EPS) for the twelve months ending March 31, 2025 was $12.29, a 81% increase year-over-year.

  • Eli Lilly EPS for the quarter ending March 31, 2025 was $3.06, a 23.39% increase year-over-year.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Eli Lilly EPS - Earnings per Share 2010-2025 | LLY

  • Eli Lilly EPS for the quarter ending March 31, 2025 was $3.06, a 23.39% increase year-over-year.
  • Eli Lilly 2024 annual EPS was $11.71, a 101.9% increase from 2023.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B